Original Article
Abnormality of Gait as a Predictor of Non-Alzheimer's Dementia
N Engl J Med 2002; 347:1761-1768November 28, 2002
- Abstract
Background
Neurologic abnormalities affecting gait occur early in several types of non-Alzheimer's dementias, but their value in predicting the development of dementia is uncertain.
Methods
We analyzed the relation between neurologic gait status at base line and the development of dementia in a prospective study involving 422 subjects older than 75 years of age who lived in the community and did not have dementia at base line. Cox proportional-hazards regression analysis was used to calculate hazard ratios with adjustment for potential confounding demographic, medical, and cognitive variables.
Results
At enrollment, 85 subjects had neurologic gait abnormalities of the following types: unsteady gait (in 31 subjects), frontal gait (in 12 subjects), hemiparetic gait (in 11 subjects), neuropathic gait (in 11 subjects), ataxic gait (in 10 subjects), parkinsonian gait (in 8 subjects), and spastic gait (in 2 subjects). During follow-up (median duration, 6.6 years), there were 125 newly diagnosed cases of dementia, 70 of them cases of Alzheimer's disease and 55 cases of non-Alzheimer's dementia (47 of which involved vascular dementia and 8 of which involved other types of dementia). Subjects with neurologic gait abnormalities had a greater risk of development of dementia (hazard ratio, 1.96 [95 percent confidence interval, 1.30 to 2.96]). These subjects had an increased risk of non-Alzheimer's dementia (hazard ratio, 3.51 [95 percent confidence interval, 1.98 to 6.24]), but not of Alzheimer's dementia (hazard ratio, 1.07 [95 percent confidence interval, 0.57 to 2.02]). Of non-Alzheimer's dementias, abnormal gait predicted the development of vascular dementia (hazard ratio, 3.46 [95 percent confidence interval, 1.86 to 6.42]). Among the types of abnormal gait, unsteady gait predicted vascular dementia (hazard ratio, 2.61), as did frontal gait (hazard ratio, 4.32) and hemiparetic gait (hazard ratio, 13.13).
Conclusions
The presence of neurologic gait abnormalities in elderly persons without dementia at base line is a significant predictor of the risk of development of dementia, especially non-Alzheimer's dementia.
Media in This Article
Video
Examples of Gait Abnormalities.
Figure 1
Kaplan-Meier Curves for the Cumulative Risk of Any Dementia (Panel A), Vascular Dementia (Panel B), and Alzheimer's Disease (Panel C) According to Gait Status at Enrollment.Article Activity
- Article
Video
Examples of Gait Abnormalities.
Gait disorders become increasingly common with advancing age, occurring in 8 to 19 percent of elderly persons residing in the community.1,2 Common causes of abnormal gait in elderly persons include neurologic diseases, arthritis, and acquired foot deformities. Neurologic diseases such as neuropathies, stroke, and parkinsonian syndromes account for 30 to 50 percent of cases in elderly patients who present for evaluation of abnormal gait.2-5 Like the frequency of gait disorders, the prevalence of dementia also increases with age.6 Although Alzheimer's disease is the most common type of dementia, vascular and other non-Alzheimer's dementias account for 30 to 50 percent of all cases of dementia.6-9 The prevalence of vascular dementia is high worldwide and is particularly high in Asia.6,9 Patients with vascular dementia may be more depressed, have greater functional impairment, and require different diagnostic and therapeutic approaches than patients with Alzheimer's disease.10 Recent studies have focused on identifying persons who are at high risk for Alzheimer's disease, often with the use of cognitive tests.11,12 Predictors of non-Alzheimer's dementia have been less well characterized.13,14
According to current criteria, the early appearance of abnormalities of gait makes a diagnosis of probable Alzheimer's disease unlikely.15,16 In contrast, gait disorders are a well-known presenting feature of non-Alzheimer's dementias such as vascular and parkinsonian dementias.17-21 Because gait abnormalities are often present at the onset of non-Alzheimer's dementia, we hypothesized that they may precede and predict diagnosis.
For 21 years, the Bronx Aging Study has conducted detailed clinical evaluations of a community-based cohort of subjects who did not have dementia at base line,22,23 providing an opportunity to identify risk factors for non-Alzheimer's dementia. We examined the role of abnormal gait in predicting not only the risk of dementia, but also the risk of Alzheimer's disease as compared with non-Alzheimer's dementia.
Methods
Study Population
Study design and recruitment methods for the Bronx Aging Study have been described previously.22,23 Briefly, we enrolled English-speaking subjects between 75 and 85 years of age. Criteria for exclusion included a previous diagnosis of idiopathic Parkinson's disease, liver disease, alcoholism, or known terminal illness; visual or hearing impairment that interfered with completion of neuropsychological tests; and presence of dementia. The inception cohort was middle-class, mostly white (90 percent), and largely female (64.5 percent). Subjects were screened to rule out dementia and were included if they made 8 or fewer errors on the Blessed Information–Memory–Concentration test (worst possible score, 32 errors).24 This test has high test–retest reliability (0.86) and correlates well with the pathology of Alzheimer's disease.25,26 Subjects were interviewed about their medical history with the use of structured questionnaires. Functional status was assessed with the subscale for activities of daily living from the Blessed Dementia Scale.24 Whenever possible, a close friend or family member was also interviewed by a study clinician in order to confirm the history and assess functional status. Written informed consent was obtained at enrollment, and subjects were asked to consider eventual participation in an autopsy program. The local institutional review board approved the study protocol.
A total of 488 subjects were enrolled between 1980 and 1983, and the study period ended in 2001. In 1992, the Bronx Aging Study was incorporated into the Einstein Aging Study. Subjects had follow-up visits every 12 to 18 months, at which they underwent detailed neurologic and neuropsychological evaluations. We excluded 65 subjects who did not have a follow-up visit, either because they died, because they moved, or because they declined to return.22,23 We excluded one subject both of whose legs had been amputated above the knee. After these exclusions, 422 subjects (86.5 percent) remained eligible for the study. Although 79 subjects subsequently dropped out of the study, the mean (±SD) follow-up was similar among the 8 subjects with abnormal gait who dropped out and the 71 without abnormal gait who dropped out (6.6±4.2 years vs. 7.2±5 years, P=0.70).
Assessment of Gait
Neurologic abnormalities affecting gait were diagnosed after clinical examination by board-certified neurologists.2,3,27 Gait impairments due solely to nonneurologic causes such as arthritis were not classified as abnormal gait. Gait abnormalities were subclassified as unsteady, ataxic, frontal, parkinsonian, neuropathic, hemiparetic, or spastic.2,3,27 Examples of the first six types of gait abnormalities are shown in Videos (available with the full text of this article at http://www.nejm.org). Gait was classified as unsteady if two or more of the following features were present: marked swaying, loss of balance, or falls while the subject was walking, walking in a straight line placing one foot directly in front of the other, or turning. Ataxic gait (resulting from cerebellar ataxia) is a wide-based gait with other features associated with cerebellar disease, such as heel-to-shin incoordination or intention tremor. Frontal gait is characterized by short steps, a wide base, and difficulty in picking the feet up off the floor (magnetic response). Elderly persons with parkinsonian gaits take small, shuffling steps, have a flexed posture, do not swing their arms, make en bloc turns, exhibit festination, and have postural instability. Patients with neuropathic gaits have unilateral or bilateral foot drop and other neuropathic signs such as a “stocking”-pattern sensory loss and an absence of deep-tendon reflexes. Patients with hemiparetic gait swing their legs outward and in a semicircle from the hip (circumduction). They usually have a history or other clinical signs of stroke. In spastic gait, both legs circumduct, and when this abnormality is severe, the legs cross in front of one another (scissoring).
To assess the reliability of the evaluations of gait, we compared assessments performed a year apart at the first and second study visits. We excluded subjects whose scores on the Blessed Information–Memory–Concentration test increased by more than two points in order to eliminate persons with changes in gait that might be related to progressive neurodegenerative disease. For the remaining 189 subjects, there was 89 percent agreement between the two assessments in the classification of gaits as neurologically normal or abnormal (kappa, 0.61).28 We have previously reported good interrater reliability for retrospective abstraction of data (kappa, 0.57 to 0.90).29
Neuropsychological Evaluation
A battery of neuropsychological tests was administered at study visits in order to assess the following cognitive domains: general cognitive status, assessed by the Blessed Information–Memory–Concentration test24 and the verbal and performance IQ according to the Wechsler Adult Intelligence Scale30; attention, assessed by the Digit Span subtest of the Wechsler Adult Intelligence Scale30; executive function, assessed by the Digit–Symbol Substitution subtest of the Wechsler Adult Intelligence Scale30; memory, assessed by the Fuld Object-Memory Evaluation31 and the five-item Blessed memory phrase subtest30 (the selective reminding test, an extensively validated memory test, was not administered at the first visit, and results on this test are not reported here); visual–perceptual processing, assessed by Raven's Progressive Matrices, Set A,32 and by the Object-Assembly subtest of the Wechsler Adult Intelligence Scale30; motor skills, assessed by the Purdue Pegboard test33; language skills, assessed by the Category Fluency Test34; and mood, assessed by the self-rating Zung depression scale.35
Diagnosis of Dementia
Subjects in whom dementia was suspected on the basis of clinical and neuropsychological evaluations, worsening scores on the Blessed Information–Memory–Concentration test, or the observations of study investigators underwent a workup.22,23 The presence or absence of gait impairment was not used to trigger evaluation. The workup included computed tomographic scanning and blood tests (complete blood count, routine chemical screen, liver-function and thyroid-function tests, measurement of vitamin B12 and folate levels, and serologic testing for syphilis) and did not vary with gait status. Diagnoses of dementia were assigned according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, third edition (DSM-III),36 at case conferences attended by at least one study neurologist, a neuropsychologist, and a geriatric nurse or social worker. Beginning in 1986, the criteria of the revised edition of the DSM-III (DSM-III-R) were used to diagnose dementia.37 Alzheimer's disease was diagnosed according to the criteria for probable disease detailed by the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association.15 Vascular dementia was diagnosed according to the criteria of the DSM-III and DSM-III-R36,37 and by a Hachinski Ischemic Score of more than 2 on the modified 12-point scale.17
At the original case conferences, clinicians had access to clinical data, including gait status, which created the potential for circularity in diagnosis. In addition, criteria for diagnosing subtypes of dementia were published after the study began.18-20 To avoid such circularity and to ensure that uniform diagnostic criteria would be used for subtypes of dementia, all cases were reassessed in 2001 by a neurologist and a neuropsychologist who were unaware of the subjects' gait status and who had not participated in the original case conferences. Clinical details were abstracted from clinical records and functional-assessment questionnaires24 and were presented to the diagnostic team by an assistant in neuropsychology who omitted all references to gait, use of canes or walkers, and limitations on activities of daily living because of poor mobility. Dementia was diagnosed according to the criteria of the DSM-III-R,37 and the subtype was determined according to standard criteria for probable or possible Alzheimer's disease,15 vascular dementia (according to the criteria for probable, possible, or mixed disease defined by the State of California Alzheimer's Disease Diagnostic and Treatment Centers),18 and dementia with Lewy bodies (according to the revised consensus criteria for probable or possible disease).20 Disagreements between raters were resolved by consensus after the presentation of the case to a second neurologist who was also blinded to gait status. Since our aim was to define the role of abnormal gait in predicting dementias other than Alzheimer's disease, we analyzed pure and mixed vascular dementias together.
Statistical Analysis
We used either the t-test for independent samples or the Mann–Whitney nonparametric test for comparisons of continuous variables and chi-square or Fisher's exact tests, as appropriate, for comparisons of categorical variables. To determine the effect of any neurologic gait abnormality and the effects of specific subtypes of gait abnormalities on the development of dementia, we used Cox proportional-hazards regression analysis to estimate hazard ratios with 95 percent confidence intervals, with adjustment for potentially confounding demographic, medical, and cognitive-status variables.38 The time to an event was calculated from enrollment to the date of a diagnosis of dementia, or to the final contact or visit in subjects in whom dementia did not develop. Kaplan–Meier survival plots were generated to represent graphically the effect of base-line gait status on the development of dementia.
Results
Demographics
Of the 422 subjects, 85 (20.1 percent) had neurologic gait abnormalities at base line. During 2609 person-years of follow-up (median follow-up, 6.6 years), dementia developed in 125 subjects, of whom 37 had abnormal gaits and 88 had normal gaits at enrollment. A total of 70 cases of dementia were subclassified by blinded raters as Alzheimer's disease, and 55 were classified as non-Alzheimer's dementia (47 of them as vascular dementia and 8 as other types of dementia). After the end of this study, all cases were reviewed by raters with full knowledge of subjects' gait and mobility status. There was good agreement between the assessments by blinded observers and those by unblinded observers, with only one additional case of dementia diagnosed and five cases of Alzheimer's disease reclassified as mixed dementias as a result of the unblinded assessment. There were no significant differences in demographic or medical variables according to base-line gait, except for age and a history of stroke, which was more common in subjects with abnormal gait (Table 1Table 1
Clinical Characteristics of Study Subjects According to Gait Status at Base Line.).Neuropsychological Testing
Subjects' performance on the neuropsychological tests is summarized in Table 2Table 2
Base-Line Performance on Neuropsychological Tests.. Subjects with neurologic gait abnormalities had a significantly lower mean performance IQ (P=0.001) but not a significantly lower mean verbal IQ (P=0.34).30 Subjects with abnormal gait also had significantly worse performance on tests of visual–perceptual processing (Raven's Progressive Matrices and the Object-Assembly test),30,32 motor skills (Purdue Pegboard test),33 and language skills (Category Fluency test).34 There were no significant differences in scores on the Blessed Information–Memory–Concentration test24 or the Zung depression scale.35 Subjects with abnormal gait had significantly lower scores on the Fuld Object-Memory Evaluation31 but not on the Blessed Memory Phrase test.24 Abnormal Gait
There was no significant difference in the incidence of Alzheimer's disease according to base-line gait status (Table 3Table 3
Incidence of Dementia among 337 Subjects with Normal Gait and 85 Subjects with Abnormal Gait at Base Line.). However, subjects with abnormal gaits were more likely to have a non-Alzheimer's dementia, such as vascular dementia.Subjects with abnormal gaits had an increased risk of dementia (hazard ratio, 1.96; 95 percent confidence interval, 1.30 to 2.96) (Table 4Table 4
Hazard Ratios for Any Dementia, Non-Alzheimer's Dementia, and Vascular Dementia, According to Type of Abnormal Gait at Base Line.), particularly non-Alzheimer's dementia (hazard ratio, 3.51; 95 percent confidence interval, 1.98 to 6.24), but did not have an increased risk of Alzheimer's disease (hazard ratio, 1.07; 95 percent confidence interval, 0.57 to 2.02), after adjustment for potential confounders. The effect of gait on the risk of non-Alzheimer's dementia is, in large part, accounted for by the association between abnormal gait and vascular dementia (hazard ratio, 3.46; 95 percent confidence interval, 1.86 to 6.42).Adjustment for neuropsychological variables in addition to base-line scores on the Blessed Information–Memory–Concentration test24 had minimal effects on the association between gait and dementia. For instance, the hazard ratio for the development of dementia was 1.82 (95 percent confidence interval, 1.20 to 2.75) after adjustment for the results on the Fuld Object-Memory Evaluation31 and 2.03 (95 percent confidence interval, 1.27 to 3.53) after adjustment for base-line performance IQ scores.30 The cumulative risk of dementia (Figure 1AFigure 1
Kaplan-Meier Curves for the Cumulative Risk of Any Dementia (Panel A), Vascular Dementia (Panel B), and Alzheimer's Disease (Panel C) According to Gait Status at Enrollment.) and the cumulative risk of vascular dementia (Figure 1B), but not the cumulative risk of Alzheimer's disease (Figure 1C), were influenced by the base-line gait status.Types of Abnormal Gait
A total of 31 subjects had unsteady gait at base line, 12 had frontal gait, 11 had hemiparetic gait, 11 had neuropathic gait, 10 had ataxic gait, 8 had parkinsonian gait, and 2 had spastic gait. Unsteady gait was associated with an increased risk of vascular dementia (hazard ratio, 2.61; 95 percent confidence interval, 1.14 to 5.99), as was frontal gait (hazard ratio, 4.32; 95 percent confidence interval, 1.26 to 14.83) and hemiparetic gait (hazard ratio, 13.13; 95 percent confidence interval, 4.81 to 35.81) (Table 4).
Pathology
Autopsies were performed in 48 of the 330 study subjects who died (14.5 percent). Postmortem examinations were performed by persons who were unaware of subjects' clinical status, and diagnoses were assigned according to established criteria.39 The final diagnosis included 4 cases of Alzheimer's disease, 5 cases of mixed dementia, 11 cases of vascular dementia, 4 cases of dementia with Lewy bodies, and 2 cases of argyrophilic grain disease.40 The remaining 22 subjects in whom autopsies were performed did not have dementia. Vascular dementia was more common in subjects with abnormal gait than in those with normal gait, affecting 45 percent of subjects with abnormal gait in whom dementia was confirmed at autopsy. Antemortem diagnosis of vascular dementia had a sensitivity of 70 percent and a specificity of 100 percent. The frequencies of lacunes, stroke, hippocampal sclerosis, and leukoencephalopathy did not differ significantly according to gait status, although microinfarctions were somewhat more common among subjects with abnormal gait (31 percent vs. 9 percent, P=0.07).
Discussion
In this cohort of elderly persons residing in the community who did not have dementia at base line, subjects with neurologic gait abnormalities were at increased risk for the development of dementia. The presence of neurologic gait abnormalities strongly predicted non-Alzheimer's dementia, especially vascular dementia, but not Alzheimer's disease. The association between gait status and the risk of non-Alzheimer's dementia remained strong even after adjustment for demographic, medical, and base-line cognitive variables. Our findings are supported by a previous study, which found that elderly persons with a combination of cognitive, vascular, and extrapyramidal features including abnormal gait were at increased risk of progression to dementia over a three-year period.41
Specific subtypes of abnormal gaits were associated with an increased risk of dementia. Videos showing representative examples of six of these gait abnormalities are available with the full text of this article at http://www.nejm.org. Elderly persons are at high risk for dementia after stroke, especially if they already have a degenerative disease.14,42 It is not surprising that subjects with hemiparetic gait had the highest risk of vascular dementia. Frontal gait in the elderly may result from cerebrovascular disease.27 On the other hand, the predictive role of unsteady gait in the elderly is intriguing. Unsteady gait may have many causes, resulting from both age-related and disease-related changes at various neuroanatomical sites. Unsteady gait may be a marker of cerebrovascular lesions, accounting for the association with dementia. However, further study in this area is required.
An unexpected finding of our study was that the presence of abnormal gaits predicted the risk of non-Alzheimer's dementia well into the future. Although an abrupt onset of dementia might be expected after stroke, our findings suggest a long prodrome, in which incremental lesions or interactions between vascular risk factors may set in motion processes that lead to dementia. These brain processes may produce abnormal gait early in their course and only much later manifest as dementia.43,44 Elderly men with APOE ε4 genotype and white-matter lesions visible on neuroimaging have been reported to be at high risk for immobility and dementia, because of impaired brain-repair mechanisms or an increased susceptibility to brain injury in persons with this genotype.45
We found a distinct neuropsychological profile involving impairment in performance IQ but sparing verbal IQ in subjects with abnormal gaits, suggesting possible functional and anatomical correlates. Persons with vascular dementia may have better verbal memory than those with Alzheimer's disease but greater impairment of executive functioning.46 Other non-Alzheimer's dementias, such as dementia with Lewy bodies,20 are also associated with distinct profiles that may provide clues to their natural history.
Our study has several limitations. First, the subjects were volunteers who resided in the community; white persons and subjects older than 75 years of age who might have a greater burden of chronic disease were overrepresented, potentially limiting the generalizability of our results. Second, assignment of subtypes of dementia is fallible. Although the diagnoses were made according to standardized criteria by a well-established procedure, some misclassification is inevitable. We used blinded assessments to avoid circularity in diagnosis, but reanalysis using diagnoses determined by unblinded observers did not alter the association of gait with dementia. Third, abnormal gait would not be predictive of Alzheimer's disease even if cases of mixed dementia were analyzed together with cases of Alzheimer's disease (hazard ratio, 1.61 [95 percent confidence interval, 0.94 to 2.78]), suggesting that gait influences risk of vascular dementia and not Alzheimer's disease in the mixed cases. Fourth, although experienced clinicians assessed gait, quantitative analysis of gait might be more reliable. Fifth, attrition is a major issue of concern in any longitudinal study, but we had relatively complete follow-up over a long observational period, reducing potential selection bias.
Clinical and pathological definitions of vascular dementia are controversial.47,48 Current clinical criteria are criticized for being either too sensitive or too specific.47,48 Dementia can follow cortical strokes, lacunar infarctions, or diffuse ischemic lesions.14,18,19 Thus, there are several subtypes of vascular dementia, which vary in their causes, pathogenesis, and clinical phenotypes. There is substantial overlap in pathology between vascular dementia and Alzheimer's disease on autopsy,49 and vascular mechanisms are implicated in the pathogenesis of both Alzheimer's and vascular dementias.13 Among subjects with dementia in our autopsy series the prevalence of vascular pathology increased with age.50
Our study provides a clinical profile for elderly persons at high risk for non-Alzheimer's dementia, particularly vascular dementia. The high-risk group defined at base line accounts for almost a third of subjects in whom vascular dementia eventually developed and identifies such subjects with a specificity of 84 percent. If replicated, these findings would provide a strategy for identifying a group at very high risk for vascular dementia and would facilitate the introduction of preventive interventions designed to reduce the incidence of non-Alzheimer's dementia, especially vascular dementia.
Supported by a grant (AGO3949-15) from the National Institute on Aging.
We are indebted to Dr. Leslie Wolfson for his helpful comments on the manuscript; to our subjects for participating in the videos; to Jijo James, M.D., Roderick Spears, M.D., and Charlotte Magnotta for help in producing the videos; and to Michael Rowling of CIR Systems for assistance in producing the footfall clips.
Source Information
From the Department of Neurology (J.V., R.B.L., C.B.H., G.K., M.J.K., H.B.) and the Department of Epidemiology and Social Medicine (R.B.L., C.B.H.), Albert Einstein College of Medicine, Bronx, N.Y.; and Innovative Medical Research and the Center for Healthier Aging (Advanced PCS), Hunt Valley, Md. (R.B.L.).
Address reprint requests to Dr. Verghese at the Einstein Aging Study, Albert Einstein College of Medicine, 1165 Morris Park Ave., Bronx, NY 10461, or at jverghes@aecom.yu.edu.
- References
References
1
Dawson D, Hendershot G, Fulton J. Aging in the eighties: functional limitations of individuals age 65 and over. Advance data from vital and health statistics. No. 133. Hyattsville, Md.: National Center for Health Statistics, 1987:1-11. (DHHS publication no. (PHS) 87-1250.)
2
Sudarsky L . Geriatrics: gait disorders in the elderly. N Engl J Med 1990;322:1441-1446
Full Text | Web of Science | Medline3
Alexander NB . Differential diagnosis of gait disorders in older adults. Clin Geriatr Med 1996;12:689-703
Web of Science | Medline4
Bloem BR ,Haan J ,Lagaay AM ,van Beek W ,Wintzen AR ,Roos RA . Investigation of gait in elderly subjects over 88 years of age. J Geriatr Psychiatry Neurol 1992;5:78-84
Medline5
Fuh J-L ,Lin K-N ,Wang S-J ,Ju T-H ,Chang R ,Liu H-C . Neurologic diseases presenting with gait impairment in the elderly. J Geriatr Psychiatry Neurol 1994;7:89-92
Medline6
Fratiglioni L ,De Ronchi D ,Aguero-Torres H . Worldwide prevalence and incidence of dementia. Drugs Aging 1999;15:365-375
CrossRef | Web of Science | Medline7
Chui H . Vascular dementia, a new beginning: shifting focus from clinical phenotype to ischemic brain injury. Neurol Clin 2000;18:951-978
CrossRef | Web of Science | Medline8
Ikeda M ,Hokoishi K ,Maki N , et al. Increased prevalence of vascular dementia in Japan: a community-based epidemiological study. Neurology 2001;57:839-844
Web of Science | Medline9
Jorm AF ,Jolley D . The incidence of dementia: a meta-analysis. Neurology 1998;51:728-733
Web of Science | Medline10
Groves WC ,Brandt J ,Steinberg M , et al. Vascular dementia and Alzheimer's disease: is there a difference? A comparison of symptoms by disease duration. J Neuropsychiatry Clin Neurosci 2000;12:305-315
CrossRef | Web of Science | Medline11
Hall CB ,Lipton RB ,Sliwinski M ,Stewart WF . A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease. Stat Med 2000;19:1555-1566
CrossRef | Web of Science | Medline12
Elias MF ,Beiser A ,Wolf PA ,Au R ,White RF ,D'Agostino RB . The preclinical phase of Alzheimer's disease: a 22-year prospective study of the Framingham Cohort. Arch Neurol 2000;57:808-813
CrossRef | Web of Science | Medline13
Skoog I . Status of risk factors for vascular dementia. Neuroepidemiology 1998;17:2-9
CrossRef | Web of Science | Medline14
Tatemichi TK ,Paik M ,Bagiella E , et al. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 1994;44:1885-1891
Web of Science | Medline15
McKhann G ,Drachman D ,Folstein M ,Katzman R ,Price D ,Stadlan EM . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944
Web of Science | Medline16
Ala TA ,Frey WH II . Validation of the NINCDS-ADRDA criteria regarding gait in the clinical diagnosis of Alzheimer's disease: a clinicopathologic study. Alzheimer Dis Assoc Disord 1995;9:152-159
Web of Science | Medline17
Rosen WG ,Terry RD ,Fuld PA ,Katzman R ,Peck A . Pathological verification of ischemic score in the differentiation of dementias. Ann Neurol 1980;7:486-488
CrossRef | Web of Science | Medline18
Chui HC ,Victoroff JI ,Margolin D ,Jagust W ,Shankle R ,Katzman R . Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California's Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480
Web of Science | Medline19
Roman GC ,Tatemichi TK ,Erkinjutti T , et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260
Web of Science | Medline20
McKeith IG ,Perry EK ,Perry RH . Report of the second Dementia with Lewy Body International Workshop: diagnosis and treatment. Neurology 1999;53:902-905
Web of Science | Medline21
Whitman GT ,Tang Y ,Lin A ,Baloh RW ,Tang T . A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 2001;57:990-994[Erratum, Neurology 2001;57:1942.]
Web of Science | Medline22
Katzman R ,Aronson M ,Fuld P , et al. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol 1989;25:317-324
CrossRef | Web of Science | Medline23
Aronson MK ,Ooi WL ,Morgenstern H , et al. Women, myocardial infarction, and dementia in the very old. Neurology 1990;40:1102-1106
Web of Science | Medline24
Blessed G ,Tomlinson BE ,Roth M . The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811
CrossRef | Web of Science | Medline25
Fuld PA. Psychological testing in the differential diagnosis of the dementias. In: Katzman R, Terry RD, Bick KL, eds. Alzheimer's disease: senile dementia and related disorders. Vol. 7 of Aging. New York: Raven Press, 1978:185-93.
26
Grober E ,Dickson D ,Sliwinski MJ , et al. Memory and mental status correlates of modified Braak staging. Neurobiol Aging 1999;20:573-579
CrossRef | Web of Science | Medline27
Nutt JG ,Marsden CD ,Thompson PD . Human walking and higher-level gait disorders, particularly in the elderly. Neurology 1993;43:268-279
Web of Science | Medline28
Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: John Wiley, 1981:38-46.
29
Verghese J ,Crystal HA ,Dickson DW ,Lipton RB . Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology 1999;53:1974-1982
Web of Science | Medline30
Wechsler D. Manual for the Wechsler Adult Intelligence Scale. Washington, D.C.: Psychological Corp., 1955.
31
Fuld PA ,Masur DM ,Blau AD ,Crystal H ,Aronson MK . Object-Memory Evaluation for prospective detection of dementia in normal functioning elderly: predictive and normative data. J Clin Exp Neuropsychol 1990;12:520-528
CrossRef | Web of Science | Medline32
Raven JC. Guide to the standard progressive matrices. Washington, D.C.: Psychological Corp., 1977.
33
Tiffin J. Purdue Pegboard test. Chicago: Science Research, 1948.
34
Isaacs B ,Kennie AT . The Set test as an aid to the detection of dementia in old people. Br J Psychiatry 1973;123:467-470
CrossRef | Web of Science | Medline35
Zung WWK . Depression in the normal aged. Psychosomatics 1967;8:287-292
Web of Science | Medline36
Diagnostic and statistical manual of mental disorders, 3rd ed.: DSM-III. Washington, D.C.: American Psychiatric Association, 1980.
37
Diagnostic and statistical manual of mental disorders, 3rd ed. rev.: DSM-III-R. Washington, D.C.: American Psychiatric Association, 1987.
38
Cox DR . Regression models and life-tables. J R Stat Soc [B] 1972;34:187-22039
Hyman BT ,Trojanowski JQ . Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997;56:1095-1097
CrossRef | Web of Science | Medline40
Braak H ,Braak E . Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 1989;15:13-26
CrossRef | Web of Science | Medline41
Waite LM ,Broe GA ,Grayson DA ,Creasey H . Preclinical syndromes predict dementia: the Sydney Older Persons Study. J Neurol Neurosurg Psychiatry 2001;71:296-302
CrossRef | Web of Science | Medline42
Henon H ,Durieu I ,Guerouaou D ,Lebert F ,Pasquier F ,Leys D . Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 2001;57:1216-1222
Web of Science | Medline43
Kotsoris H ,Barclay LL ,Kheyfets S ,Hulyalkar A ,Dougherty J . Urinary and gait disturbances as markers for early multi-infarct dementia. Stroke 1987;18:138-141
CrossRef | Web of Science | Medline44
Hennerici MG ,Oster M ,Cohen S ,Schwartz A ,Motsch L ,Daffertshofer M . Are gait disturbances and white matter degeneration early indicators of vascular dementia? Dementia 1994;5:197-202
Medline45
Carmelli D ,DeCarli C ,Swan GE , et al. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function. J Gerontol A Biol Sci Med Sci 2000;55:M103-M109
CrossRef | Web of Science | Medline46
Looi JCL ,Sachdev PS . Differentiation of vascular dementia from AD on neuropsychological tests. Neurology 1999;53:670-678
Web of Science | Medline47
Chui HC ,Mack W ,Jackson JE , et al. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol 2000;57:191-196
CrossRef | Web of Science | Medline48
Knopman DS ,DeKosky ST ,Cummings JL , et al. Practice parameter: diagnosis of dementia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1143-1153
Web of Science | Medline49
Esiri MM . Which vascular lesions are of importance in vascular dementia? Ann N Y Acad Sci 2000;903:239-243
CrossRef | Web of Science | Medline50
Crystal HA ,Dickson D ,Davies P ,Masur D ,Grober E ,Lipton RB . The relative frequency of “dementia of unknown etiology“ increases with age and is nearly 50% in nonagenarians. Arch Neurol 2000;57:713-719
CrossRef | Web of Science | Medline
- Citing Articles (102)
Citing Articles
1
Anand Viswanathan, Lewis Sudarsky. 2012. Balance and gait problems in the elderly. , 623-634.
CrossRef2
Philip D. Thompson. 2012. Frontal lobe ataxia. , 619-622.
CrossRef3
M. Jamour, C. Becker, M. Synofzik, W. Maetzler. (2012) Gangveränderungen als Frühindikator einer Demenz. Zeitschrift für Gerontologie und Geriatrie 45:1, 40-44
CrossRef4
Hidekazu Tomimoto. (2011) Subcortical vascular dementia. Neuroscience Research 71:3, 193-199
CrossRef5
Jagan A. Pillai, Charles B. Hall, Dennis W. Dickson, Herman Buschke, Richard B. Lipton, Joe Verghese. (2011) Association of Crossword Puzzle Participation with Memory Decline in Persons Who Develop Dementia. Journal of the International Neuropsychological Society 17:06, 1006-1013
CrossRef6
G. Abellan van Kan, Y. Rolland, S. Gillette-Guyonnet, V. Gardette, C. Annweiler, O. Beauchet, S. Andrieu, B. Vellas. (2011) Gait Speed, Body Composition, and Dementia. The EPIDOS-Toulouse Cohort. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
CrossRef7
Álvaro Casas Herrero, Nicolás Martínez Velilla, Francisco Javier Alonso Renedo. (2011) Deterioro cognitivo y riesgo de caída en el anciano. Revista Española de Geriatría y Gerontología
CrossRef8
C. Rosano, S. A. Studenski, H. J. Aizenstein, R. M. Boudreau, W. T. Longstreth, A. B. Newman. (2011) Slower gait, slower information processing and smaller prefrontal area in older adults. Age and Ageing
CrossRef9
Kevin M. Sailor, Molly E. Zimmerman, Amy E. Sanders. (2011) Differential impacts of age of acquisition on letter and semantic fluency in Alzheimer's disease patients and healthy older adults. The Quarterly Journal of Experimental Psychology1-9
CrossRef10
Zhengdong Lu, Todd K. Leen, Jeffrey Kaye. (2011) Kernels for Longitudinal Data with Variable Sequence Length and Sampling Intervals. Neural Computation 23:9, 2390-2420
CrossRef11
R. Holtzer, J. R. Mahoney, M. Izzetoglu, K. Izzetoglu, B. Onaral, J. Verghese. (2011) fNIRS Study of Walking and Walking While Talking in Young and Old Individuals. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 66A:8, 879-887
CrossRef12
José Alberto Ávila-Funes, S. D. Pina-Escudero, S. Aguilar-Navarro, L. M. Gutierrez-Robledo, L. Ruiz-Arregui, Hélène Amieva. (2011) Cognitive impairment and low physical activity are the components of frailty more strongly associated with disability. The journal of nutrition, health & aging 15:8, 683-689
CrossRef13
Orit Segev-Jacubovski, Talia Herman, Galit Yogev-Seligmann, Anat Mirelman, Nir Giladi, Jeffrey M Hausdorff. (2011) The interplay between gait, falls and cognition: can cognitive therapy reduce fall risk?. Expert Review of Neurotherapeutics 11:7, 1057-1075
CrossRef14
Mooyeon Oh-Park, Xiaonan Xue, Roee Holtzer, Joe Verghese. (2011) Transient Versus Persistent Fear of Falling in Community-Dwelling Older Adults: Incidence and Risk Factors. Journal of the American Geriatrics Society 59:7, 1225-1231
CrossRef15
Moon Ho Park, Joo Young Min, Do-Young Kwon, Seung Hwan Lee, Hae Ri Na, Sung Tae Cho, Duk L. Na. (2011) Vascular risk factors and the effect of white matter lesions on extrapyramidal signs in Alzheimer's disease. International Psychogeriatrics 23:05, 780-787
CrossRef16
Friedrich Leblhuber, Katharina Schroecksnadel, Margit Beran-Praher, Herbert Haller, Kostja Steiner, Dietmar Fuchs. (2011) Polyneuropathy and dementia in old age: common inflammatory and vascular parameters. Journal of Neural Transmission 118:5, 721-725
CrossRef17
Farzaneh A. Sorond, Lewis A. Lipsitz. 2011. Aging and the Cerebral Microvasculature. , 347-371.
CrossRef18
Roee Holtzer, Melissa Shuman, Jeannette R. Mahoney, Richard Lipton, Joe Verghese. (2010) Cognitive Fatigue Defined in the Context of Attention Networks. Aging, Neuropsychology, and Cognition 18:1, 108-128
CrossRef19
Marta San Luciano, Richard B. Lipton, Cuiling Wang, Mindy Katz, Molly E. Zimmerman, Amy E. Sanders, Laurie J. Ozelius, Susan B. Bressman, Rachel Saunders-Pullman. (2010) Clinical expression of LRRK2 G2019S mutations in the elderly. Movement Disorders 25:15, 2571-2576
CrossRef20
Jeannette Y. Wick, Guido R. Zanni. (2010) Tiptoeing Around Gait Disorders: Multiple Presentations, Many Causes. The Consultant Pharmacist 25:11, 724-737
CrossRef21
Mooyeon Oh-Park, Roee Holtzer, Xiaonan Xue, Joe Verghese. (2010) Conventional and Robust Quantitative Gait Norms in Community-Dwelling Older Adults. Journal of the American Geriatrics Society 58:8, 1512-1518
CrossRef22
Richard B. Lipton, Jamie Hirsch, Mindy J. Katz, Cuiling Wang, Amy E. Sanders, Joe Verghese, Nir Barzilai, Carol A. Derby. (2010) Exceptional Parental Longevity Associated with Lower Risk of Alzheimer's Disease and Memory Decline. Journal of the American Geriatrics Society 58:6, 1043-1049
CrossRef23
Hubertus Axer, Martina Axer, Heinrich Sauer, Otto W. Witte, Georg Hagemann. (2010) Falls and gait disorders in geriatric neurology. Clinical Neurology and Neurosurgery 112:4, 265-274
CrossRef24
J. Verghese, X. Xue. (2010) Identifying frailty in high functioning older adults with normal mobility. Age and Ageing 39:3, 382-385
CrossRef25
Gilles Allali, Bruno Dubois, Frederic Assal, Elise Lallart, Leonardo C. de Souza, Maxime Bertoux, Cédric Annweiler, Francois R. Herrmann, Richard Levy, Olivier Beauchet. (2010) Frontotemporal dementia: Pathology of gait?. Movement Disorders 25:6, 731-737
CrossRef26
Joe Verghese, Anne F. Ambrose, Richard B. Lipton, Cuiling Wang. (2010) Neurological gait abnormalities and risk of falls in older adults. Journal of Neurology 257:3, 392-398
CrossRef27
R. Holtzer, L. Ozelius, X. Xue, T. Wang, R.B. Lipton, J. Verghese. (2010) Differential effects of COMT on gait and executive control in aging. Neurobiology of Aging 31:3, 523-531
CrossRef28
H. H. Atkinson, S. R. Rapp, J. D. Williamson, J. Lovato, J. R. Absher, M. Gass, V. W. Henderson, K. C. Johnson, J. B. Kostis, K. M. Sink, C. P. Mouton, J. K. Ockene, M. L. Stefanick, D. S. Lane, M. A. Espeland. (2010) The Relationship Between Cognitive Function and Physical Performance in Older Women: Results From the Women's Health Initiative Memory Study. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 65A:3, 300-306
CrossRef29
F. Nourhashémi, M. G. Olde Rikkert, A. Burns, B. Winblad, G. B. Frisoni, J. Fitten, B. Vellas. (2010) Follow-up for Alzheimer patients: European Alzheimer disease consortium position paper. The journal of nutrition, health & aging 14:2, 121-130
CrossRef30
Velandai Srikanth, Lauren Sanders, Michele Callisaya, Kara Martin, Thanh Phan. (2010) Brain aging and gait. Aging Health 6:1, 123-131
CrossRef31
Thurmon Lockhart, Sukwon Kim, Radhika Kapur, Shannon Jarrott. (2009) Evaluation of Gait Characteristics and Ground Reaction Forces in Cognitively Declined Older Adults With an Emphasis on Slip-Induced Falls. Assistive Technology 21:4, 188-195
CrossRef32
Neelesh K. Nadkarni, Elysha Mawji, William E. McIlroy, Sandra E. Black. (2009) Spatial and temporal gait parameters in Alzheimer's disease and aging. Gait & Posture 30:4, 452-454
CrossRef33
Frédéric Jean, Alexandra Branzan Albu, Robert Bergevin. (2009) Towards view-invariant gait modeling: Computing view-normalized body part trajectories. Pattern Recognition 42:11, 2936-2949
CrossRef34
Deborah E Barnes, Kristine Yaffe. (2009) Predicting dementia: role of dementia risk indices. Future Neurology 4:5, 555-560
CrossRef35
Molly E. Zimmerman, Richard B. Lipton, Jullie W. Pan, Hoby P. Hetherington, Joe Verghese. (2009) MRI- and MRS-derived hippocampal correlates of quantitative locomotor function in older adults. Brain Research 1291, 73-81
CrossRef36
D.T.H. Lai, R.K. Begg, M. Palaniswami. (2009) Computational Intelligence in Gait Research: A Perspective on Current Applications and Future Challenges. IEEE Transactions on Information Technology in Biomedicine 13:5, 687-702
CrossRef37
J. Verghese, R. Holtzer, R. B. Lipton, C. Wang. (2009) Quantitative Gait Markers and Incident Fall Risk in Older Adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 64A:8, 896-901
CrossRef38
Paul K. Canavan, Lawrence P. Cahalin, Susan Lowe, Diane Fitzpatrick, Meredith Harris, Prudence Plummer-D'Amato. (2009) Managing Gait Disorders in Older Persons Residing in Nursing Homes: A Review of Literature. Journal of the American Medical Directors Association 10:4, 230-237
CrossRef39
José Alberto ÃVila-Funes, Hélène Amieva, Pascale Barberger-Gateau, Mélanie Le Goff, Nadine Raoux, Karen Ritchie, Isabelle Carrière, Béatrice Tavernier, Christophe Tzourio, Luis Miguel Gutiérrez-Robledo, Jean-François Dartigues. (2009) Cognitive Impairment Improves the Predictive Validity of the Phenotype of Frailty for Adverse Health Outcomes: The Three-City Study. Journal of the American Geriatrics Society 57:3, 453-461
CrossRef40
Klaus Hauer, Daniel Hüger, Tania Zieschang, Michael Schwenk, Peter Oster, Clemens Becker, Klaus Hauer. (2009) Designing studies on the effectiveness of physical training in patients with cognitive impairment. Zeitschrift für Gerontologie und Geriatrie 42:1, 11-19
CrossRef41
M. B. v. Iersel, R. P. C. Kessels, B. R. Bloem, A. L. M. Verbeek, M. G. M. Olde Rikkert. (2008) Executive Functions Are Associated With Gait and Balance in Community-Living Elderly People. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 63:12, 1344-1349
CrossRef42
N. B. Alexander, J. M. Hausdorff. (2008) Guest Editorial: Linking Thinking, Walking, and Falling. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 63:12, 1325-1328
CrossRef43
A. E. Sanders, R. Holtzer, R. B. Lipton, C. Hall, J. Verghese. (2008) Egocentric and Exocentric Navigation Skills in Older Adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 63:12, 1356-1363
CrossRef44
Maria L. Nieto, Steven M. Albert, Lisa A. Morrow, Judith Saxton. (2008) Cognitive Status and Physical Function in Older African Americans. Journal of the American Geriatrics Society 56:11, 2014-2019
CrossRef45
P. Manckoundia, F. Mourey, P. Pfitzenmeyer. (2008) Marche et démences. Annales de Réadaptation et de Médecine Physique 51:8, 692-700
CrossRef46
H. H. Dodge, Y. Kita, H. Takechi, T. Hayakawa, M. Ganguli, H. Ueshima. (2008) Healthy Cognitive Aging and Leisure Activities Among the Oldest Old in Japan: Takashima Study. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 63:11, 1193-1200
CrossRef47
Joe Verghese, Matthew Robbins, Roee Holtzer, Molly Zimmerman, Cuiling Wang, Xiaonan Xue, Richard B. Lipton. (2008) Gait Dysfunction in Mild Cognitive Impairment Syndromes. Journal of the American Geriatrics Society 56:7, 1244-1251
CrossRef48
Stanley J. Birge. (2008) Osteoporotic fractures: A brain or bone disease?. Current Osteoporosis Reports 6:2, 57-61
CrossRef49
G. Atzmon, T. I. Pollin, J. Crandall, K. Tanner, C. B. Schechter, P. E. Scherer, M. Rincon, G. Siegel, M. Katz, R. B. Lipton, A. R. Shuldiner, N. Barzilai. (2008) Adiponectin Levels and Genotype: A Potential Regulator of Life Span in Humans. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 63:5, 447-453
CrossRef50
H. Stolze, P. Vieregge, G. Deuschl. (2008) Gangstörungen in der Neurologie. Der Nervenarzt 79:4, 485-499
CrossRef51
Kara Bottiggi, Anne L. Harrison. (2008) The association between change in motor function and cognition in older adults: a descriptive review. Physical Therapy Reviews 13:2, 91-101
CrossRef52
Galit Yogev-Seligmann, Jeffrey M. Hausdorff, Nir Giladi. (2008) The role of executive function and attention in gait. Movement Disorders 23:3, 329-342
CrossRef53
Judy MA Haworth. (2008) Gait, aging and dementia. Reviews in Clinical Gerontology 18:01, 39
CrossRef54
Jeffrey Kaye. (2008) Home-based technologies: A new paradigm for conducting dementia prevention trials. Alzheimer's and Dementia 4:1, S60-S66
CrossRef55
Matheus Roriz-Cruz, Idiane Rosset, Taizo Wada, Teiji Sakagami, Masayuki Ishine, Jarbas De Sá Roriz-Filho, Thadeu R.S. Cruz, Mohsen Hosseinkhani, Rosalina P. Rodrigues, Shinji Sudoh, Hidenori Arai, Yoshio Wakatsuki, Antonio C. Souza, Masanori Nakagawa, Toru Kita, Kozo Matsubayashi. (2007) Cognitive impairment and frontal-subcortical geriatric syndrome are associated with metabolic syndrome in a stroke-free population. Neurobiology of Aging 28:11, 1723-1736
CrossRef56
R. Camicioli, Y. Wang, C. Powell, A. Mitnitski, K. Rockwood. (2007) Gait and posture impairment, parkinsonism and cognitive decline in older people. Journal of Neural Transmission 114:10, 1355-1361
CrossRef57
J. Verghese, C. Derby, M. J. Katz, R. B. Lipton. (2007) High risk neurological gait syndrome and vascular dementia. Journal of Neural Transmission 114:10, 1249-1252
CrossRef58
Winston H. Wu, Alex A. T. Bui, Maxim A. Batalin, Duo Liu, William J. Kaiser. (2007) Incremental Diagnosis Method for Intelligent Wearable Sensor Systems. IEEE Transactions on Information Technology in Biomedicine 11:5, 553-562
CrossRef59
John R. Merory, Joanne E. Wittwer, Christopher C. Rowe, Kate E. Webster. (2007) Quantitative gait analysis in patients with dementia with Lewy bodies and Alzheimer's disease. Gait & Posture 26:3, 414-419
CrossRef60
Neill R. Graff-Radford. (2007) Normal Pressure Hydrocephalus. Neurologic Clinics 25:3, 809-832
CrossRef61
Marco Inzitari, Claudia Pozzi, Lucio A. Rinaldi, Giulio Masotti, Niccolò Marchionni, Mauro Di Bari. (2007) Cognitive and functional impairment in hypertensive brain microangiopathy. Journal of the Neurological Sciences 257:1-2, 166-173
CrossRef62
P. A. Boyle, R. S. Wilson, A. S. Buchman, N. T. Aggarwal, Y. Tang, Z. Arvanitakis, J. Kelly, D. A. Bennett. (2007) Lower Extremity Motor Function and Disability in Mild Cognitive Impairment. Experimental Aging Research 33:3, 355-371
CrossRef63
J. G. F. Coutinho, M. P. T. Juvonen, J. L. Wang, B. L. Lo, W. Luk, O. Mencer, G. Z. Yang. (2007) Designing a Posture Analysis System with Hardware Implementation. The Journal of VLSI Signal Processing Systems for Signal, Image, and Video Technology 47:1, 33-45
CrossRef64
Diana Paleacu, Agatha Shutzman, Nir Giladi, Talia Herman, Ely S. Simon, Jeffrey M. Hausdorff. (2007) Effects of Pharmacological Therapy on Gait and Cognitive Function in Depressed Patients. Clinical Neuropharmacology 30:2, 63-71
CrossRef65
2007. Stance and Gait. , 57-74.
CrossRef66
Marco Inzitari, Anne B. Newman, Kristine Yaffe, Robert Boudreau, Nathalie de Rekeneire, Ronald Shorr, Tamara B. Harris, Caterina Rosano. (2007) Gait Speed Predicts Decline in Attention and Psychomotor Speed in Older Adults: The Health Aging and Body Composition Study. Neuroepidemiology 29:3-4, 156-162
CrossRef67
Debra Morgan, Melanie Funk, Margaret Crossley, Jenny Basran, Andrew Kirk, Vanina Dal Bello-Haas. (2007) The Potential of Gait Analysis to Contribute to Differential Diagnosis of Early Stage Dementia: Current Research and Future Directions. Canadian Journal on Aging / La Revue canadienne du vieillissement 26:01, 19
CrossRef68
2007. Reliability of Physical Findings. , 28-46.
CrossRef69
Pamela L. Sheridan, Jeffrey M. Hausdorff. (2007) The Role of Higher-Level Cognitive Function in Gait: Executive Dysfunction Contributes to Fall Risk in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders 24:2, 125-137
CrossRef70
Anke H Snijders, Bart P van de Warrenburg, Nir Giladi, Bastiaan R Bloem. (2007) Neurological gait disorders in elderly people: clinical approach and classification. The Lancet Neurology 6:1, 63-74
CrossRef71
Timothy Schmutte, Shelby Harris, Ross Levin, Richard Zweig, Mindy Katz, Richard Lipton. (2007) The Relation Between Cognitive Functioning and Self-Reported Sleep Complaints in Nondemented Older Adults: Results From the Bronx Aging Study. Behavioral Sleep Medicine 5:1, 39-56
CrossRef72
Gustavo C. Román, Raj N. Kalaria. (2006) Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiology of Aging 27:12, 1769-1785
CrossRef73
Johannes Attems, Magdalena Quass, Kurt A. Jellinger. (2006) Tau and α-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs. Acta Neuropathologica 113:1, 53-62
CrossRef74
Anne Ambrose, Aaron LeValley, Joe Verghese. (2006) A comparison of community-residing older adults with frontal and parkinsonian gaits. Journal of the Neurological Sciences 248:1-2, 215-218
CrossRef75
Richard Camicioli, Thomas Bouchard, Lisa Licis. (2006) Dual-tasks and walking fast: Relationship to extra-pyramidal signs in advanced Alzheimer disease. Journal of the Neurological Sciences 248:1-2, 205-209
CrossRef76
K Hauer, C Becker, U Lindemann, N Beyer. (2006) Effectiveness of Physical Training on Motor Performance and Fall Prevention in Cognitively Impaired Older Persons. American Journal of Physical Medicine & Rehabilitation 85:10, 847-857
CrossRef77
R. C. Shah, R. S. Wilson, J. L. Bienias, Z. Arvanitakis, D. A. Evans, D. A. Bennett. (2006) Blood Pressure and Lower Limb Function in Older Persons. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61:8, 839-843
CrossRef78
Rachel Saunders-Pullman, Richard B. Lipton, Geetha Senthil, Mindy Katz, Camille Costan-Toth, Carol Derby, Susan Bressman, Joe Verghese, Laurie J. Ozelius. (2006) Increased frequency of the LRRK2 G2019S mutation in an elderly Ashkenazi Jewish population is not associated with dementia. Neuroscience Letters 402:1-2, 92-96
CrossRef79
Mahesh Krishnamurthy, Joe Verghese. (2006) Gait Characteristics in Nondisabled Community-Residing Nonagenarians. Archives of Physical Medicine and Rehabilitation 87:4, 541-545
CrossRef80
Joe Verghese, Aaron LeValley, Charles B. Hall, Mindy J. Katz, Anne F. Ambrose, Richard B. Lipton. (2006) Epidemiology of Gait Disorders in Community-Residing Older Adults. Journal of the American Geriatrics Society 54:2, 255-261
CrossRef81
Julie A. Schneider, Jia-Liang Li, Yan Li, Robert S. Wilson, Jeffrey H. Kordower, David A. Bennett. (2006) Substantia nigra tangles are related to gait impairment in older persons. Annals of Neurology 59:1, 166-173
CrossRef82
Roee Holtzer, Joe Verghese, Xiaonan Xue, Richard B. Lipton. (2006) Cognitive Processes Related to Gait Velocity: Results From the Einstein Aging Study.. Neuropsychology 20:2, 215-223
CrossRef83
Louise M. Allan, Clive G. Ballard, David J. Burn, Rose Anne Kenny. (2005) Prevalence and Severity of Gait Disorders in Alzheimer's and Non-Alzheimer's Dementias. Journal of the American Geriatrics Society 53:10, 1681-1687
CrossRef84
Galit Yogev, Nir Giladi, Chava Peretz, Shmuel Springer, Ely S. Simon, Jeffrey M. Hausdorff. (2005) Dual tasking, gait rhythmicity, and Parkinson's disease: Which aspects of gait are attention demanding?. European Journal of Neuroscience 22:5, 1248-1256
CrossRef85
Jeffrey M Hausdorff, Galit Yogev, Shmuel Springer, Ely S. Simon, Nir Giladi. (2005) Walking is more like catching than tapping: gait in the elderly as a complex cognitive task. Experimental Brain Research 164:4, 541-548
CrossRef86
Erin Hawkes, Jeff Schulz, Christopher Shaw. 2005. Cycad Consumption and Neurological Disease. .
CrossRef87
Hansjoerg Baezner, Michael Hennerici. (2005) From trepidant abasia to motor network failure—gait disorders as a consequence of subcortical vascular encephalopathy (SVE). Journal of the Neurological Sciences 229-230, 81-88
CrossRef88
N. Giladi, T. Herman, I. I. Reider-Groswasser, T. Gurevich, J. M. Hausdorff. (2005) Clinical characteristics of elderly patients with a cautious gait of unknown origin. Journal of Neurology 252:3, 300-306
CrossRef89
L.M. Waite, D.A. Grayson, O. Piguet, H. Creasey, H.P. Bennett, G.A. Broe. (2005) Gait slowing as a predictor of incident dementia: 6-year longitudinal data from the Sydney Older Persons Study. Journal of the Neurological Sciences 229-230, 89-93
CrossRef90
T. Herman, N. Giladi, T. Gurevich, J.M. Hausdorff. (2005) Gait instability and fractal dynamics of older adults with a “cautious” gait: why do certain older adults walk fearfully?. Gait & Posture 21:2, 178-185
CrossRef91
Samantha Galluzzi, Ching-Fan Sheu, Orazio Zanetti, Giovanni B. Frisoni. (2005) Distinctive Clinical Features of Mild Cognitive Impairment with Subcortical Cerebrovascular Disease. Dementia and Geriatric Cognitive Disorders 19:4, 196-203
CrossRef92
A.F. Pettersson, E. Olsson, L.-O. Wahlund. (2005) Motor Function in Subjects with Mild Cognitive Impairment and Early Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders 19:5-6, 299-304
CrossRef93
Joe Verghese, Richard B. Lipton, Dennis W. Dickson, Howard A. Crystal. (2004) A Clinicopathological Study of Rest Tremors in the Elderly. Journal of the American Geriatrics Society 52:10, 1781-1783
CrossRef94
H.-K. Kuo, L. A. Lipsitz. (2004) Cerebral White Matter Changes and Geriatric Syndromes: Is There a Link?. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:8, M818-M826
CrossRef95
Nir Barzilai, Luciano Rossetti, Richard B. Lipton. (2004) Einstein's institute for aging research: collaborative and programmatic approaches in the search for successful aging. Experimental Gerontology 39:2, 151-157
CrossRef96
John M Kinney. (2004) Nutritional frailty, sarcopenia and falls in the elderly. Current Opinion in Clinical Nutrition and Metabolic Care 7:1, 15-20
CrossRef97
Gustavo C. Rom??n. (2003) Vascular dementia: changing the paradigm. Current Opinion in Psychiatry 16:6, 635-641
CrossRef98
C.A Shaw, J.M.B Wilson. (2003) Analysis of neurological disease in four dimensions: insight from ALS-PDC epidemiology and animal models. Neuroscience & Biobehavioral Reviews 27:6, 493-505
CrossRef99
Verghese, Joe, Lipton, Richard B., Katz, Mindy J., Hall, Charles B., Derby, Carol A., Kuslansky, Gail, Ambrose, Anne F., Sliwinski, Martin, Buschke, Herman, . (2003) Leisure Activities and the Risk of Dementia in the Elderly. New England Journal of Medicine 348:25, 2508-2516
Full Text100
(2003) Current Awareness in Geriatric Psychiatry. International Journal of Geriatric Psychiatry 18:3, 267-274
CrossRef101
(2003) Anti-Aging Medicine LiteratureWatch. Journal of Anti-Aging Medicine 6:1, 45-64
CrossRef102
. (2003) Abnormale gang voorspelt dementie. Huisarts en Wetenschap 46:2, 872-872
CrossRef
